SCIESCOPUSQ2
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
ELSEVIER SCIENCE INC, United States
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS is an academic journal published by ELSEVIER SCIENCE INC (United States). Identifiers: ISSN 1078-1439, eISSN 1873-2496. Indexed in SCIE, SCOPUS. Metrics: JIF 2.3, CiteScore 5.0, SJR 0.855, SNIP 0.79. Subject areas: ONCOLOGY, UROLOGY & NEPHROLOGY. tlooto lists 1,592 papers from this journal.
CiteScore
5.00
Scopus citation metric
SJR
0.855
SCImago rank
SNIP
0.79
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1078-1439
- eISSN
- 1873-2496
- Abbreviation
- UROL ONCOL-SEMIN ORI
- Publisher
- ELSEVIER SCIENCE INC
- Country
- United States
Web of Science categories
SCIEONCOLOGY, UROLOGY & NEPHROLOGY
Scopus ASJC categories
2730 Oncology2748 Urology
Keywords
Oncology | Urology & Nephrology
Papers in this journal
Recent papers
- Prostate cancer deaths will decrease by 2050.
2026
- Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer.
2026
- Effective PD-1 checkpoint blockade in bladder cancer model requires tumor-draining lymph nodes and lymphocyte trafficking.
2026
- Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeries.
2026
- Survivor-identified barriers and facilitators to acute phase recovery following radical cystectomy.
2026
Most cited papers
- Why most published research findings are false: Ioannidis JP, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece
2008 · 749 citations
- Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs) 1 1 J Bone Joint Surg Am 2003;85A:1544–52
2003 · 530 citations
- Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. 1 1 H. Barton Grossman, M.D
2002 · 312 citations
- Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial
2003 · 168 citations
- Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911)
2006 · 167 citations